Avanos Medical Inc (AVNS)

Cash ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash and cash equivalents US$ in thousands 107,700 89,000 92,200 75,800 87,700 107,100 81,800 95,700 127,700 117,000 106,500 104,300 118,500 97,800 99,900 100,100 111,500 180,000 185,000 187,700
Short-term investments US$ in thousands
Total current liabilities US$ in thousands 165,900 212,900 208,200 205,200 234,600 170,700 160,500 158,500 185,800 162,300 151,100 152,900 139,200 129,200 158,300 154,600 166,300 179,400 176,000 189,400
Cash ratio 0.65 0.42 0.44 0.37 0.37 0.63 0.51 0.60 0.69 0.72 0.70 0.68 0.85 0.76 0.63 0.65 0.67 1.00 1.05 0.99

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($107,700K + $—K) ÷ $165,900K
= 0.65

The cash ratio of Avanos Medical Inc has shown some fluctuation over the years. Generally, the cash ratio measures the company's ability to cover its short-term liabilities with its available cash. A cash ratio of 1 or higher is considered healthy, indicating the company can cover its current liabilities with its cash on hand.

Looking at the data provided, we see that the cash ratio of Avanos Medical Inc ranged from a high of 1.05 in June 2020 to a low of 0.37 in December 2023 and March 2024. The ratio improved slightly in subsequent quarters but remained below 1, indicating the company may have had some difficulty covering its short-term obligations with its cash reserves during those periods.

It is important to note that a low cash ratio could suggest that the company may need to rely on other sources of liquidity, such as short-term borrowing or liquidation of other assets, to meet its obligations. Analysts and investors typically monitor the cash ratio along with other liquidity ratios to assess a company's financial health and ability to manage its short-term financial obligations.